Summary & Overview
CPT 00164: Anesthesia for Nasal and Sinus Soft Tissue Biopsy
CPT code 00164 covers anesthesia for soft tissue biopsy procedures on the nose and accessory sinuses, a service essential for accurate diagnosis and treatment of nasal and sinus disorders. This code is widely recognized across major national payers, including Aetna, Blue Cross Blue Shield, Cigna Health, and UnitedHealthcare, ensuring broad coverage for patients undergoing these procedures.
The publication provides a comprehensive overview of 00164, detailing its clinical context, typical site of service, and relevance in hospital operating rooms. Readers will gain insights into payer coverage, common billing modifiers, and associated clinical taxonomies. The summary also highlights related CPT codes and ICD-10 diagnoses frequently linked to nasal and sinus biopsies, offering a clear understanding of how this code fits within broader anesthesiology and otolaryngology practices.
Key benchmarks and policy updates are discussed, equipping healthcare professionals, administrators, and billing specialists with the latest information on coding, reimbursement, and clinical application. This resource is designed to support informed decision-making and compliance in medical billing and documentation for anesthesia services related to nasal and sinus biopsies.
CPT Code Overview
CPT code 00164 is designated for anesthesia services provided during procedures on the nose and accessory sinuses, specifically for soft tissue biopsy. This code falls under the Anesthesiology service type and is most commonly performed in the Operating Room (Hospital), corresponding to Place of Service 22. The procedure involves the administration of anesthesia to ensure patient comfort and safety during nasal and sinus biopsies, which are critical for diagnosing various conditions affecting these structures.
Clinical & Coding Specifications
Clinical Context
A patient presents with chronic nasal symptoms such as congestion, obstruction, or recurrent sinus infections. After evaluation by an otolaryngologist, a biopsy of soft tissue within the nose or accessory sinuses is indicated to rule out neoplastic or inflammatory conditions. The procedure is performed in the hospital operating room (POS 22) under anesthesia. An anesthesiologist or a certified registered nurse anesthetist (CRNA) provides anesthesia care, ensuring patient safety and comfort during the biopsy. The clinical workflow includes preoperative assessment, administration of anesthesia, intraoperative monitoring, and postoperative recovery.
Coding Specifications
-
Modifiers:
QS: Monitored anesthesia care service. Used when the anesthesia provider delivers monitored anesthesia care (MAC) during the procedure.QX: CRNA service with medical direction by a physician. Used when a CRNA provides anesthesia care under the medical direction of an anesthesiologist.
-
Provider Taxonomies:
| Taxonomy Code | Specialty Name |
|---|---|
207L00000X | Anesthesiology |
207LA0401X | Pain Medicine (Anesthesiology) |
207LC0200X | Critical Care Medicine (Anesthesiology) |
- Specialties Represented:
- Anesthesiology
- Pain Medicine (Anesthesiology)
- Critical Care Medicine (Anesthesiology)
Related Diagnoses
-
J34.2– Deviated nasal septum- Relevant when a biopsy is performed to evaluate structural abnormalities or associated pathology.
-
J32.9– Chronic sinusitis, unspecified- Indicates chronic inflammation of the sinuses, which may necessitate biopsy to rule out underlying causes.
-
J34.89– Other specified disorders of nose and nasal sinuses- Used for less common nasal or sinus conditions requiring tissue diagnosis.
-
J33.9– Nasal polyp, unspecified- Biopsy may be performed to assess polyps for neoplastic or inflammatory changes.
-
J34.3– Hypertrophy of nasal turbinates- Biopsy may be indicated to evaluate hypertrophic tissue for underlying pathology.
Related CPT Codes
| CPT Code | Description | Clinical Relationship |
|---|---|---|
00160 | Anesthesia for procedures on nose and accessory sinuses; not otherwise specified | Used for anesthesia in nasal/sinus procedures not specifically described by other codes. May be an alternative to 00164 when the procedure is not a biopsy. |
00162 | Anesthesia for procedures on nose and accessory sinuses; radical surgery | Used for anesthesia in more extensive or radical nasal/sinus surgeries. Not typically used with 00164, but may be selected for more complex cases. |
00170 | Anesthesia for intraoral procedures, including biopsy | Used for anesthesia in procedures involving the oral cavity, including biopsies. May be used as an alternative if the biopsy is intraoral rather than nasal. |
- These codes are alternatives to
00164depending on the specific procedure performed. They are not commonly used together but may be selected based on the surgical approach and site.
National Reimbursement Benchmarks
National mean rates for CPT code 00164 show that Blue Cross Blue Shield and Cigna have the highest average reimbursement, at $240.27 and $249.05 respectively. UnitedHealth Group is notably lower, with a mean rate of $65.63. The BUCA average commercial mean rate is $122.84, which is significantly higher than typical Medicare rates, though Medicare data is not available in the input for this code.
Rate dispersion varies considerably across payers. UnitedHealth Group has the tightest range between the 25th and 75th percentiles ($75.80 - $50.33 = $25.47), indicating less variability in payment rates. Cigna exhibits the widest spread ($348.00 - $90.00 = $258.00), suggesting substantial variation in reimbursement. Blue Cross Blue Shield and Aetna also show broad ranges, with $157.25 and $220.00 respectively.
The table and chart below present the full breakdown of national benchmarks for CPT code 00164 by payer.
State Benchmarks
State: AK1 / 50
Alaska Benchmarks
Alaska demonstrates a significant spread in reimbursement rates for CPT code 00164 across commercial payers. Blue Cross Blue Shield shows the widest rate spread, with a 75th percentile of $300.00 and a 25th percentile of $225.80, resulting in a $74.20 difference. In contrast, Aetna, Cigna, and UnitedHealth Group all have much narrower spreads, with their 25th and 75th percentiles differing by only $4.00 or less, indicating more consistent rates among these payers.
Compared to national averages, Blue Cross Blue Shield and Aetna in Alaska offer higher mean rates, while Cigna and UnitedHealth Group are below their national benchmarks. The table and chart below present the full breakdown of mean and percentile rates by payer for Alaska, highlighting these variations in reimbursement.
Key Insights for Alaska
- Blue Cross Blue Shield is the highest paying payer for CPT 00164 in Alaska, with a mean rate of $269.31.
- UnitedHealth Group offers the lowest mean rate at $75.12.
- Mean rates for Aetna and Blue Cross Blue Shield in Alaska are notably higher than their respective national averages, while Cigna and UnitedHealth Group are below national benchmarks.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.